Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (4 ops.)
Latest filing published 28 Apr 2026 for Abbott Laboratories.
Filing timeline
BuySaleMichael O'Grady
Insider track record
Disclosed buys
1
Disclosed sells
4
Signal history
Closed purchases
Market purchases
1
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +54.3%Entry US$64.95 · Close at T+365 US$100.19
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Michael O'Grady: trading record in brief
Michael O'Grady, Chairman and CEO of Northern Trust Corp (75 filings) and a Director at Abbott Laboratories (4), has sold EUR 14.5 million in 4 sales, with a median of EUR 3,923,369. The three largest are from December 9, 2021 (EUR 5,047,366), May 5, 2021 (EUR 4,172,909) and May 6, 2021 (EUR 3,673,830). A single purchase is on file, EUR 1,220,260 at Northern Trust Corp on October 23, 2023, or 20% of market trades.
The record holds 79 filings published from January 21, 2016 to April 28, 2026, with 63 grants, 7 option exercises and 4 other filings. 2021 is the busiest year with 13 filings, against 4 in 2016; from 2022 to 2025 the pace is 8 or 9 a year. Eight filings fall in the last twelve months, with no purchase and no sale.
At Northern Trust Corp, Jason J. Tyler and Thomas A. South each have 4 trades within 30 days of O'Grady's, Joyce St Clair and Lauren E. Allnutt 3, all in the same direction. The publication delay is 2 days at the median.
Companies and markets linked to Michael O'Grady
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations79 total
2,286 shares0Common shares without par valueSEC:0001527742-26-000012:0
11,129 shares@ US$143.158.3% of flowCommon StockSEC:0001527742-26-000011:0
32,181 shares@ US$147.246.9% of flowCommon StockSEC:0001527742-26-000009:1
72,642 shares0Common StockSEC:0001527742-26-000009:0
19,437 shares0Common StockSEC:0001527742-26-000007:0
21,739 shares@ US$150.784.7% of flowCommon StockSEC:0001527742-26-000005:1
34,489 shares@ US$58.2510.3% of flowCommon StockSEC:0001527742-26-000005:0
770 shares@ US$131.320.5% of flowCommon StockSEC:0001527742-25-000005:0
1,635 shares0Common shares without par valueSEC:0001415889-25-011526:0
11,684 shares@ US$110.277.6% of flowCommon StockSEC:0000073124-25-000137:0
27,957 shares@ US$112.695.2% of flowCommon StockSEC:0000073124-25-000099:1
63,107 shares0Common StockSEC:0000073124-25-000099:0
19,012 shares0Common StockSEC:0000073124-25-000066:0
17,432 shares@ US$113.213.3% of flowCommon StockSEC:0000073124-25-000031:1
23,739 shares@ US$70.219.8% of flowCommon StockSEC:0000073124-25-000031:0
1,366 shares@ US$110.310.9% of flowCommon StockSEC:0000073124-24-000298:0
1,866 shares0Common shares without par valueSEC:0001415889-24-011797:0
10,673 shares@ US$81.905.0% of flowCommon StockSEC:0000073124-24-000091:0
33,734 shares0Common StockSEC:0000073124-24-000056:0
26,618 shares@ US$79.513.4% of flowCommon StockSEC:0000073124-24-000038:1
60,085 shares0Common StockSEC:0000073124-24-000038:0
20,333 shares@ US$81.382.6% of flowCommon StockSEC:0000073124-24-000021:1
24,651 shares@ US$60.858.5% of flowCommon StockSEC:0000073124-24-000021:0
1,282 shares@ US$80.360.6% of flowCommon StockSEC:0000073124-23-000208:0
20,000 shares@ US$65.107.5% of flowCommon StockSEC:0000073124-23-000192:0
Canonical exit: 21 Jan 2024 (T+90)
25 of 79 declarations
